Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan R Vavricka

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Gastroenterology|November 3, 2004
hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cellsStephan R Vavricka, Mark W Musch, Jonathan E Chang, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Therapeutic Advances in Gastroenterology|May 16, 2022
Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance studyStephan R Vavricka, Thomas Greuter, Benjamin L Cohen, et al.
Swiss Medical Weekly|September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practiceLaura Rossier, Christoph Matter, Emanuel Burri, et al.
Journal of Crohn'S & Colitis|February 16, 2017
Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant MechanismsHassan Melhem, Marianne R Spalinger, Jesus Cosin-Roger, et al.
Inflammatory Bowel Diseases|October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel DiseaseChristian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Inflammatory Bowel Diseases|March 1, 2013
Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort studyUwe Siebert, Johannes Wurm, Raffaella Matteucci Gothe, et al.
United European Gastroenterology Journal|May 4, 2023
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort studyBélène Podmore, Dominik Beier, Johan Burisch, et al.
Digestion|June 20, 2016
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre ExperienceMehdi Madanchi, Jonas Zeitz, Christiane Barthel, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Gastroenterology|November 3, 2004
hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cellsStephan R Vavricka, Mark W Musch, Jonathan E Chang, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Therapeutic Advances in Gastroenterology|May 16, 2022
Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance studyStephan R Vavricka, Thomas Greuter, Benjamin L Cohen, et al.
Swiss Medical Weekly|September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practiceLaura Rossier, Christoph Matter, Emanuel Burri, et al.
Journal of Crohn'S & Colitis|February 16, 2017
Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant MechanismsHassan Melhem, Marianne R Spalinger, Jesus Cosin-Roger, et al.
Inflammatory Bowel Diseases|October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel DiseaseChristian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Inflammatory Bowel Diseases|March 1, 2013
Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort studyUwe Siebert, Johannes Wurm, Raffaella Matteucci Gothe, et al.
United European Gastroenterology Journal|May 4, 2023
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort studyBélène Podmore, Dominik Beier, Johan Burisch, et al.
Digestion|June 20, 2016
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre ExperienceMehdi Madanchi, Jonas Zeitz, Christiane Barthel, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
Pageof 22